US pharmacy pricing
Aptivus Cost Without Insurance — US Pharmacy Price Guide
Lowest price found · US pharmacies
$2,092.59/fill
for Aptivus, across the pharmacies in our data
US pharmacy prices — 250mg
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $2,092.59Lowest | $2,095.59 | $35,000.00 | |
| $2,092.59Lowest | $2,095.59 | $35,000.00 | |
| $2,187.35 | $2,190.35 | $35,000.00 | |
| $2,188.37 | $2,188.37 | $35,000.00 | |
| $2,196.95 | $2,199.95 | $35,000.00 | |
| $2,214.02 | $2,214.02 | $35,000.00 | |
| $2,259.32 | $2,262.32 | $35,000.00 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Frequently asked questions
How much does Aptivus (Aptivus) cost without insurance?
Our most recent US pharmacy data shows a low of roughly $2,092.59 for Aptivus with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Aptivus have a generic equivalent?
Generic and brand-name pricing for Aptivus is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How much can I expect to pay for Aptivus with insurance?
The cost of Aptivus with insurance varies widely depending on your specific plan's formulary, deductible, and co-pay structure. Some plans may cover it, while others may require prior authorization or place it on a higher cost-sharing tier. If your plan does not cover Aptivus or your out-of-pocket costs are high, you may be able to use a prescription savings program or a manufacturer's patient assistance program. Patients with Medicare or Medicaid should check their plan's coverage details; if there is a gap, other pharmacy discount programs can be explored to help manage costs.
Is a generic version of Aptivus available?
No, Aptivus is currently only available as a brand-name medication from its manufacturer, Boehringer Ingelheim. There is no FDA-approved generic equivalent (tipranavir) on the market at this time.